Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002530163 | SCV000650773 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256386 | SCV002533152 | uncertain significance | Dyskeratosis congenita | 2021-05-28 | criteria provided, single submitter | curation | |
Gene |
RCV002307542 | SCV002601115 | uncertain significance | not provided | 2024-09-12 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Published functional demonstrate no increase in oxidative DNA damage, ability to recruit TRF2 to telomeres, response to DNA damage and ability to induce apoptosis similar to wild-type, however also significantly increased reactive oxygen species (PMID: 38641551); This variant is associated with the following publications: (PMID: 38641551) |
Ambry Genetics | RCV002256386 | SCV002611248 | uncertain significance | Dyskeratosis congenita | 2022-02-28 | criteria provided, single submitter | clinical testing | The p.T1101M variant (also known as c.3302C>T), located in coding exon 16 of the TERT gene, results from a C to T substitution at nucleotide position 3302. The threonine at codon 1101 is replaced by methionine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |